3641 - 3650 of 8571 Results
Title
Year
- Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB2018OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 51Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 77
- Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort Experience2020OPENTitle: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort ExperienceJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 665End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191901?id=journal-of-parkinsons-disease%2Fjpd191901Citation Count: 48
- A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels2020OPENTitle: A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium ChannelsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 9Start Page: 2539End Page: 2550Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.0c00577Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7502546Citation Count: 17
-
OPENTitle: Deep Brain Stimulation in a Case of Mitochondrial DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 3Issue #: 2Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12241Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12241Citation Count: 9
- Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders2024OPENTitle: Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disordersJournal Name: GeroSciencePublisher: Springer Science and Business Media LLCVol: 46Issue #: 5Start Page: 4397End Page: 4414Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11357-024-01120-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11357-024-01120-4.pdfCitation Count: 4
-
OPENTitle: Comparison of two protocols for the generation of iPSC-derived human astrocytesJournal Name: Biological Procedures OnlinePublisher: Springer Science and Business Media LLCVol: 25Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12575-023-00218-xBest OA location URL: https://biologicalproceduresonline.biomedcentral.com/counter/pdf/10.1186/s12575-023-00218-xCitation Count: 6
- TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice2007OPENTitle: TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 26Issue #: 1Start Page: 36End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2006.11.012Best OA location URL: http://doi.org/10.1016/j.nbd.2006.11.012Citation Count: 166
-
OPENTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 46
-
RESTRICTEDTitle: Disease-modifying therapies for Parkinson's diseaseJournal Name: The Biomedical & Life Sciences CollectionPublisher: Henry Stewart TalksVol: 2013Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.69645/krxj9755Citation Count: 0
-
RESTRICTEDTitle: Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 83End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.05.001Citation Count: 7